|
CTNNB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.37587727269783E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.48734407807206E-13 |
| Normal-vs-Stage2 |
1.16089999835367E-08 |
| Normal-vs-Stage3 |
1.79668999999993E-05 |
| Normal-vs-Stage4 |
8.26279999976975E-09 |
| Stage1-vs-Stage2 |
6.822200E-01 |
| Stage1-vs-Stage3 |
9.677400E-01 |
| Stage1-vs-Stage4 |
2.251000E-01 |
| Stage2-vs-Stage3 |
7.336000E-01 |
| Stage2-vs-Stage4 |
2.858000E-01 |
| Stage3-vs-Stage4 |
2.613800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.63566946046012E-13 |
| Normal-vs-AfricanAmerican |
1.14950049479035E-10 |
| Normal-vs-Asian |
1.35670000001031E-06 |
| Caucasian-vs-AfricanAmerican |
6.478200E-01 |
| Caucasian-vs-Asian |
4.888400E-01 |
| AfricanAmerican-vs-Asian |
5.566800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.44169137633799E-15 |
| Normal-vs-Female |
1.397040E-04 |
| Male-vs-Female |
3.461400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.87649999667295E-08 |
| Normal-vs-Extreme_Weight |
1.63025148935958E-12 |
| Normal-vs-Obese |
2.1861000010226E-08 |
| Normal-vs-Extreme_Obese |
7.721700E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.966800E-01 |
| Normal_Weight-vs-Obese |
3.762000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.230800E-01 |
| Extreme_Weight-vs-Obese |
3.808100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.991600E-01 |
| Obese-vs-Extreme_Obese |
5.176600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.378700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.1523008909603E-11 |
| Normal-vs-Age(61-80Yrs) |
1.68454139526375E-12 |
| Normal-vs-Age(81-100Yrs) |
1.05730000310444E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.866200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.648400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.562410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.229800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.920000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.111400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.05804254246777E-13 |
| Normal-VS-Type2 PRCC |
8.32645064008375E-12 |
| Normal-VS-KIRP CIMP |
1.589240E-01 |
| Normal-VS-Unclassified PRCC |
2.448300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.421600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.645600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.158800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.272960E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.953600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.997200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63835611743934E-12 |
| Normal-vs-N1 |
1.155060E-04 |
| Normal-vs-N2 |
1.259420E-01 |
| N0-vs-N1 |
3.370400E-01 |
| N0-vs-N2 |
9.102600E-01 |
| N1-vs-N2 |
7.467400E-01 |
|
|
